Assorted News from the Last Week:
Congratulations to CAC2 Members Autumn Gentry (MACC Fund, Inc) and Mariah Forster Olson (Neuroblastoma Children’s Cancer Society) with inspiration and guidance from CAC2 Board Member Ann Ramer on the publication of the Wisconsin Pediatric Cancer Action Plan. A tale of resilience: Physician fights Blue Cross of Idaho to cover her baby’s brain cancer treatment with lorlatanib. The National Institutes of Health’s (NIH) All of Us Research Program has started limited enrollment of children from birth through age 4 at five partner health care organizations across the country. Expanding participation to children offers researchers the opportunity to examine how health and disease progress through the lifespan, and starting with this age group provides the greatest potential for advancing research from infancy to childhood and adolescence. A joint university study has found a pathway to a therapy program against a rare and deadly pediatric brain tumour. Due to a lack of effective treatment, the tumours—called Posterior fossa group A (PFA) ependymoma—have the highest recurrence rate and poorest prognosis of all childhood cancers.Delving into the clinical impact of NETs in pediatric cancer.
A comprehensive overview of liquid biopsy applications in pediatric solid tumors.
Upcoming Webinars, Online Opportunities, and Meetings:
56th Congress of the International Society of Paediatric Oncology (SIOP 2024), which will take place in Honolulu, Hawaii, USA | October 17-20, 2024. Registration is open and anyone who registers before July 17, 2024 can take advantage of the discounted rates.
Take Action:
The FDA and CTTI announced the call for applications for new members of the Patient Engagement Collaborative (PEC). The PEC is an ongoing, shared forum in which the patient community (PEC members), FDA, and CTTI discuss a variety of topics such as improving communication, education, and patient engagement related to medical product regulation. Try out the monthly donation platform dedicated to childhood cancer that helps nonprofits and warrior-parents team up to raise money for research, family support, and advocacy offered at no charge by Hello Cure.CAC2 Student Member Na Ouyang, MSN, RN (PhD candidate, Yale School of Nursing) is conducting her dissertation study, which focuses on exploring how clinician-parent communication influences parents’ preparation for their child’s end-of-life and then impacts parental grief in early bereavement. Click here for information and details. Click here for the IRB Approval document.